ScreenerHero
DHCDiversified Healthcare Trust
NAS · US · Real Estate · REIT - Healthcare Facilities · dhcreit.com
9.300USD-3.23%Mkt Cap: 2.25B $P/E: —

Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by c…

Industry Peers

REIT - Healthcare Facilities
Screen all
vs REIT - Healthcare Facilities
P/B
Avg
Div Yield
Higher
1M Perf
Lower
WELL
Welltower Inc.
$160.22BUSDP/E 109.6
VTR
Ventas, Inc.
$43.17BUSDP/E 161.5
OHI
Omega Healthcare Investors, Inc.
$14.87BUSDP/E 23.0
DOC
Healthpeak Properties, Inc.
$14.75BUSDP/E 66.9
CTRE
CareTrust REIT, Inc.
$9.53BUSDP/E 25.5
HR
Healthcare Realty Trust Incorporated
$7.07BUSD
AED
Aedifica NV/SA
$6.41BUSDP/E 6.1
CSH-UN
Chartwell Retirement Residences
$5.30BUSDP/E Infinity
SBRA
Sabra Health Care REIT, Inc.
$4.92BUSDP/E 31.0
NHI
National Health Investors, Inc.
$3.70BUSDP/E 24.6
COFB
Cofinimmo SA
$3.43BUSDP/E 15.5
PHP
Primary Health Properties Plc
$2.70BUSDP/E 13.7
MPT
Medical Properties Trust, Inc.
$2.76BUSD
LTC
LTC Properties, Inc.
$1.97BUSDP/E 15.1
SILA
Sila Realty Trust, Inc.
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.08BUSD
CPINV
Care Property Invest NV
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$608.58MUSDP/E 34.3
CHCT
Community Healthcare Trust Incorporated
$522.29MUSDP/E 152.3
XRN
Chiron Real Estate Inc.
$496.57MUSD
STRW
Strawberry Fields REIT, Inc.
$184.62MUSDP/E 21.5
Indicators:|

Key Statistics

Company
Market Cap2.25B $
Enterprise Value4.55B $
Revenue (TTM)1.52B $
Gross Profit278.51M $
Net Income (TTM)-285.89M $
Revenue/Share6.310 USD
Last Price9.300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-19.58
PEG1.89
EV/EBITDA20.92
EV/Revenue3.00
P/S1.48
P/B1.39
EPS (TTM)-1.33
EPS (Forward)-0.47
52W Range
3.18094% of range9.660
52W High9.660 USD
52W Low3.180 USD
Profitability
Gross Margin18.11%
Oper. Margin-1.29%
EBITDA Margin14.33%
Profit Margin-18.59%
ROE-17.16%
ROA-6.56%
Growth
Revenue Growth-5.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.62M $
CapEx (TTM)—
FCF Margin16.31%
FCF Yield10.99%
Net Debt2.30B $
Net Debt/EBITDA10.56
Balance Sheet
Debt/Equity1.44
Current Ratio7.40
Quick Ratio6.74
Book Value/Sh6.693 USD
Cash/Share0.5030 USD
Dividends
Fwd Div Rate0.0400 USD
Trail. Div Rate0.0400 USD
Div. Yield0.43%
5Y Avg Yield1.76%
Payout Ratio2.30%
Ex-Div DateApr 21, 2026
Pay DateMay 14, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.875 USD
Upside (mean)+6.2%
Target Range8.000 USD – 11.00 USD
$8.000+6.2% to mean$11.00
# Analysts4
Ownership
Shares Out.242.11M
Float186.78M
Insiders10.32%
Institutions84.34%
Short Interest
Short Ratio5.3d
Short % Float4.67%
Short % Out.4.19%
Shares Short10.16M
Short (prev mo.)9.34M
Technical
SMA 508.412 (+10.6%)
SMA 2006.190 (+50.2%)
Beta2.29
S&P 52W Chg20.05%
Avg Vol (30d)1.69M
Avg Vol (10d)2.32M
Technical Indicators
RSI (14)59.8
MACD0.2839
MACD Signal0.2429
MACD Hist.+0.0410
BB Upper9.655 USD
BB Middle8.914 USD
BB Lower8.174 USD
BB Width16.61%
ATR (14)0.3584 USD
Vol Ratio (20d)1.08x